Vituss Tablet 50 mg (Frandrucast Hydrate)

Adult dose

Adults: Administer 50mg of pranlukast hydrate orally twice daily, after breakfast and dinner. Adjust the dose as appropriate according to symptoms.

This medication should not be taken by patients who are allergic to certain ingredients. It contains lactose, hence individuals with genetic issues such as galactose intolerance, lactase deficiency, and glucose-galactose malabsorption should avoid using this medication. Severe allergic reactions such as shock or anaphylaxis may occur during use; if symptoms arise, discontinue use immediately and seek appropriate treatment. Blood cell count reduction or liver function abnormalities may also occur, so if these symptoms appear, stop taking the medication and consult a doctor. Respiratory conditions may worsen or pneumonia symptoms may occur; if respiratory symptoms such as cough or shortness of breath arise, discontinue use and receive treatment immediately. Musculoskeletal issues such as myalgia or weakness, as well as rhabdomyolysis may develop; if such symptoms occur, discontinue the medication and consult a specialist. Hypersensitivity reactions such as skin rash, urticaria, or itching may occur, so discontinue use if these symptoms appear. Neuropsychiatric symptoms such as tremor, seizures, anxiety, headache, drowsiness, and dizziness may occur and should be monitored. Gastrointestinal issues such as nausea, abdominal pain, diarrhea, vomiting, and loss of appetite may arise; if symptoms are severe, discontinue use and consult a doctor. Cardiac rhythm disturbances or palpitations, blood pressure changes may also occur; thus, caution is advised if these symptoms present. Renal function abnormalities or urinary disorders may rarely occur, so any abnormal symptoms should be reported to healthcare providers. This medication is not an immediate reliever of asthma attacks, so patients should be advised to use bronchodilators or steroids during acute episodes. For patients on steroids who are using this medication to reduce steroid dosages, gradual adjustments should be made and caution is advised when stopping to reduce the risk of relapse. Rare complications like vasculitis may occur during use of this medication, so symptoms such as fever, joint pain, or eosinophilia should be monitored. Psychiatric symptoms such as depression, suicidal thoughts, and aggressive behavior have been reported, necessitating close observation of the patient's condition after use. If there is no response, long-term use should be avoided. This medication may interact with enzymes metabolized by the liver, so caution should be taken regarding changes in blood concentration when taking with other drugs. Pregnant women or those who may become pregnant should only take this medication when the benefits of treatment outweigh the risks, as its safety has not been fully established. Safety in children, especially low birth weight infants or neonates, has not been sufficiently confirmed thus should be used with caution. The elderly may have decreased body function, so it is preferable to reduce the dosage. This medication should be kept out of the reach of children and transferring it to another container is not recommended as it may affect quality.

• Shock
• anaphylactic symptoms
• hypotension
• altered consciousness
• dyspnea
• rash
• leukopenia
• fever
• sore throat
• general malaise

This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly sealed container. It is best to maintain storage temperatures between 1 degree and 30 degrees Celsius to preserve the effectiveness of the medication for as long as possible.

Appearance

White oval film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle